What does CUSIP 09077B104 represent in this 13F holders report?

CUSIP 09077B104 is the security identifier for BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share used to aggregate holder disclosures.

How many institutions held BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share in Q2 2022?

71 institutional investors reported BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share for Q2 2022. Use the holders table for investor-level position and value details.

BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB)

CUSIP: 09077B104

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stocks, par value $0,0001 per share
Shares outstanding: 58,548,563
Total 13F shares: 23,517,118
Share change: -1,952,495
Total reported value: $67,049,000
Put/Call ratio: 124%
Price per share: $2.85
Number of holders: 71
Value change: -$8,813,651
Number of buys: 35
Number of sells: 65

Quarterly Holders Quick Answers

What is CUSIP 09077B104?
CUSIP 09077B104 identifies BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 09077B104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	5%	2,919,403	$14,597,000	—	31 Mar 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	4.4%	2,564,697	$12,827,000	—	31 Mar 2022	13F
Soleus Capital Management, L.P.	13F	Company	4.3%	2,515,424	$12,577,000	—	31 Mar 2022	13F
Cormorant Asset Management, LP	13F	Company	3.5%	2,038,215	$10,191,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	2.7%	1,594,238	$7,970,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	2.7%	1,593,916	$7,970,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	2.7%	1,556,282	$7,782,000	—	31 Mar 2022	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	1.9%	1,100,000	$5,500,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.6%	918,844	$4,595,000	—	31 Mar 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	1.4%	825,000	$4,125,000	—	31 Mar 2022	13F
Boxer Capital, LLC	13F	Company	1.2%	686,347	$3,452,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.97%	567,425	$2,837,000	—	31 Mar 2022	13F
Guy Levy	3/4/5	Former Director	— class O/S missing	1,130,688	$2,781,493	—	16 Jun 2022	3/4/5
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.92%	536,469	$2,682,000	—	31 Mar 2022	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.85%	499,491	$2,497,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.72%	422,839	$2,114,000	—	31 Mar 2022	13F
S.c.a. Candriam	13F	Individual	0.65%	382,023	$1,910,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.52%	301,873	$1,509,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.51%	300,800	$1,504,000	—	31 Mar 2022	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.49%	289,002	$1,445,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.49%	284,961	$1,425,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.43%	251,200	$1,256,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.36%	211,089	$1,055,000	—	31 Mar 2022	13F
HRT FINANCIAL LP	13F	Company	0.34%	198,804	$994,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.32%	185,414	$927,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.31%	181,557	$908,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.3%	174,071	$871,000	—	31 Mar 2022	13F
Walleye Capital LLC	13F	Company	0.29%	170,326	$852,000	—	31 Mar 2022	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.2%	115,451	$577,000	—	31 Mar 2022	13F
Trexquant Investment LP	13F	Company	0.2%	115,365	$577,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.18%	104,744	$572,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.19%	109,836	$549,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.18%	106,047	$531,000	—	31 Mar 2022	13F
Squarepoint Ops LLC	13F	Company	0.18%	105,085	$525,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.18%	104,295	$521,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.17%	101,012	$505,000	—	31 Mar 2022	13F
PDT Partners, LLC	13F	Company	0.16%	95,423	$477,000	—	31 Mar 2022	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.16%	91,262	$456,000	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	0.15%	89,144	$445,000	—	31 Mar 2022	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.13%	73,300	$367,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.12%	71,261	$356,000	—	31 Mar 2022	13F
BARCLAYS PLC	13F	Company	0.11%	66,686	$333,000	—	31 Mar 2022	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.11%	66,620	$333,000	—	31 Mar 2022	13F
MYDA Advisors LLC	13F	Company	0.1%	60,000	$300,000	—	31 Mar 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.1%	57,200	$286,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.09%	50,760	$254,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.09%	50,200	$251,000	—	31 Mar 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.07%	41,031	$205,000	—	31 Mar 2022	13F
Jump Financial, LLC	13F	Company	0.07%	40,500	$203,000	—	31 Mar 2022	13F
Virtu Financial LLC	13F	Company	0.07%	39,229	$196,000	—	31 Mar 2022	13F

Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q2 2022

As of 30 Jun 2022, BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,517,118 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, Soleus Capital Management, L.P., JANUS HENDERSON GROUP PLC, Cormorant Asset Management, LP, VANGUARD GROUP INC, MORGAN STANLEY, RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, and BlackRock Inc.. This page lists 71 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-20

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.